Effect of gender on the outcome of patients receiving nivolumab for metastatic renal cancer: Results from a large study population.

e16087Background: Several studies, the majority on melanoma and lung cancer, have addressed the value of gender with respect to immune check point inhibitors outcome as compared to standard therapy...